Inventor
BRETT C. BOOKSER
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07CAcyclic or carbocyclic compounds15%
PatentTitleYear
12,324,802Modulators of cystic fibrosis transmembrane conductance regulator202512,269,831Modulators of cystic fibrosis transmembrane conductance regulator202511,945,808Substituted cyclohexyl compounds as NOP inhibitors202411,365,191Substituted cyclohexyl compounds as NOP inhibiiors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to DART NEUROSCIENCE LLC (2)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to VERTEX PHARMA (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DART NEUROSCIENCE LLC | 2 | 2022–2024 |
| VERTEX PHARMA | 2 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2025 |